US Government Stake Bets IonQ Micron and Anduril Emerge as Top Candidates on Kalshi DBS CEO Tan Su Shan Secures Sixth Place in Fortunes 2026 Most Powerful Women List PepsiCo Reportedly Preparing Snack Price Increases for Late June Bureau of Prisons Adopts AI Technology Large Contract Signals Shift in Facility Management Canaccord Raises Biodesix Price Target Amid Upgraded Revenue Outlook Vanguard Updates US Economic Outlook Cautious Optimism Amid Policy Uncertainty Sangoma Technologies Q1 2026 Earnings EPS Miss Weighs on Shares as Losses Widen Braemar Hotels Resorts Inc BHR Q1 2026 Earnings Massive EPS Surprise of 42178 Beats Estimates TIL Q1 2026 Earnings WiderthanExpected Loss Highlights EarlyStage Development Challenges SBEV Q2 2025 Earnings Widerthanexpected loss sends shares lower Knowles Corporation KN Q1 2026 Earnings EPS Beat Drives Stock Higher MFAO Q1 2026 Earnings Narrow Earnings Miss Reflects Stable mREIT Performance Social Commerce Partners SCPQ Consolidates Near Key Support Potential Breakout or Breakdown Ahead Lumentum Holdings LITE Holds Near 902 as Support and Resistance Levels Come into Focus Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support Nebius Group NBIS Holds Near 208 as Investors Weigh Narrow Trading Range FreightCar America RAIL Gains 178 Approaching Key Resistance Zone Perella Weinberg Partners Q1 2026 Earnings EPS Misses Estimates as Advisory Revenue Remains Undisclosed Illinois Tool Works ITW Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Modest Share Gain Crescent Capital BDC Inc CCAP Q1 2026 Earnings Slight Earnings Miss Amidst Stable Portfolio Performance Flex Ltd FLEX Q1 2026 Earnings EPS Surpasses Estimates Amid Cost Discipline Stock Edges Higher ImageneBio IMA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Pyxis Tankers Q1 2026 Earnings Strong EPS Beat Amidst Soft Share Reaction Analog Devices Projects Q3 Revenue Could Surpass Market Expectations Five Point Holdings LLC FPH Q1 2026 Earnings Negative EPS and Stock Decline Amid Quiet Quarter ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573